8.78 0.00 (0.00%)
After hours: 5:38PM EST
|Bid||8.74 x 1000|
|Ask||8.86 x 1200|
|Day's Range||8.52 - 8.89|
|52 Week Range||8.34 - 21.86|
|Beta (3Y Monthly)||0.49|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 12, 2020 - Feb 17, 2020|
|Forward Dividend & Yield||0.12 (1.39%)|
|1y Target Est||14.06|
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips. That outperformance comes with a price, however, as there are occasional periods of higher volatility. The last 12 months is one of those periods, as the Russell 2000 […]
The times, said Hart Energy's Paul Hart in opening the conference with a movie quote, are bad. But, he said, the Marcellus and Utica — one of the largest gas fields in the world — has all of the ingredients to take advantage when conditions get better.
When billionaire financier Ray Dalio makes a move, Wall Street pays attention. Dalio, who got his start working on the floor of the New York Stock Exchange trading commodity futures, founded the world’s largest hedge fund, Bridgewater Associates, in 1975. With the firm managing about $150 billion in global investments and Dalio’s own net worth coming at $18.7 billion, he has earned guru-like status by taking the opinions of experts that disagreed with him into consideration.“I learned a great fear of being wrong that shifted my mind-set from thinking ‘I’m right’ to asking myself ‘How do I know I’m right?’ And I saw clearly that the best way to answer this question is by finding other independent thinkers who are on the same mission as me and who see things differently from me,” he wrote in his book Principles.On Friday, the Wall Street Journal reported that Bridgewater made a more than $1 billion bet that the market would drop in the next few months. However, Dalio took to Twitter to deny this, claiming that the firm has no such bet. Against this backdrop, investors want to know if the fund manager is simply hedging the portfolio, or if the firm is really as bearish as the report made it out to be.Looking into Bridgewater's basket of stocks, we’ve chosen three of the fund’s new holdings that TipRanks’ Stock Screener reveals as "strong buys" and offer healthy upside potential. Let's take a closer look and see what Wall Street analysts have to say.Cleveland-Cliffs (CLF)Formerly known as Cliffs Natural Resources, Cleveland-Cliffs is one of the top iron ore mining companies and operators. Not only is it the largest iron ore producer of pellets in North America but the steel company also takes its place as one of the lowest cost producers in the world.During the third quarter, Bridgewater upped the ante by 110%, adding 2,134,146 shares of the company to the fund. This brings Bridgewater’s total CLF holding to 4,081,690 shares, valued at $29.5 million.Recently, steel prices have been facing significant pressure. Tariffs as well as the high cost of raw-materials have led to price increases, while weakening U.S. industrial production has in turn caused demand for steel to drop. Nonetheless, the bulls are standing firmly behind CLF.B.Riley FBR analyst Lucas Pipes sees its briquetted iron (HBI) growth project, which should reach production in the first half of 2020, as well as its level of diversification as giving it a leg up. “We believe that Cliffs retains considerable upside in a stronger commodity price environment in addition to the diversification and strategic benefits of the HBI project,” he commented. As a result, the analyst kept his Buy rating but did adjust his price target from $13 to $12. This implies that there’s room for 51% upside potential. (To watch Pipes’ track record, click here)Like Pipes, Credit Suisse analyst Curt Woodworth reduced the price target from $12 to $10 following CLF’s third quarter earnings results while remaining bullish overall. Even though he acknowledges that “the move lower in pellet premiums and HRC as well as mix shifts (less export) have conspired to lower the ASP outlook for CLF”, he believes that demand for HBI could be a major profit driver. He adds, “We believe the Street is too negative on CLF given optionality to benefit from new EAF production…CLF remains a best-in-class mining asset with significant FCF potential over the cycle.” (To watch Woodworth’s track record, click here)In general, the rest of the Street is in agreement. 6 Buys and 2 Holds assigned in the last three months add up to a ‘Strong Buy’ consensus. In addition, its $9.66 average price target suggests 21% upside potential. (See Cleveland-Cliffs stock analysis on TipRanks)Alexion Pharmaceuticals (ALXN) Alexion is a biopharma company trying to improve the lives of patients with rare disease including paroxysmal nocturnal hemoglobinuria (PNH), generalized Myasthenia Gravis (gMG), atypical hemolytic uremic syndrome (aHUS) as well as several others.Despite its impressive performance in its most recent quarter in terms of its financial results and solid execution commercially, shares have been weighed down by concerns over its C5 inhibitor franchise. Alexion is gearing up to face competition from biosimilar products currently in Phase 3 development. On top of this, Roche’s Japanese subsidiary, Chugai Pharmaceutical, filed a patent infringement suit against Alexion.To this end, the Street is keeping a close watch on ALXN following Dalio’s purchase. The billionaire’s fund snapped up 445,246 shares during the third quarter, bringing Bridgewater’s total ALXN stake to 475,487 shares, up a whopping 1473% from the previous quarter.Piper Jaffray analyst Christopher Raymond reminds investors that there are still big potential gains in store for ALXN in 2020. “As impressive commercial performance and pipeline development have continued, and with what we view as an increasingly credible defensive strategy to protect against biosimilar competition, we continue to like the setup on this name,” he explained. This prompted the five-star analyst to keep an Overweight rating and $180 price target. At this target, shares could climb 62% higher over the next twelve months. (To watch Raymond’s track record, click here)Similarly, other analysts have high hopes for the biopharma. With 18 Buys and 2 Holds given over the last three months, the consensus is that ALXN is a ‘Strong Buy’. Not to mention there’s 35% upside potential based on the $151 average price target. (See Alexion stock analysis on TipRanks)EQT Corporation (EQT)EQT is the largest natural gas producer in the U.S. with its asset base located in the heart of the Appalachian Basin. With shares down 52% year-to-date, investors are watching this name following Dalio’s decision to increase the fund’s holding.Dalio just added an additional 1,177,026 shares to the fund, bumping up the stake by 88% from the previous quarter. The holding’s value is now at $26.9 million, based on its total stake of 2,529,370 shares.It should be noted that several of the Street’s analysts highlight the fact the EQT is taking steps in the right direction. The management team has been using technology in order to improve its logistic and operational processes. RBC Capital analyst Scott Hanold argues this should “enable EQT to reduce well costs toward $730/lateral foot from the historical $970/foot.”On top of this, the company is potentially selling its Equitrans Midstream ownership within the next nine months, lending itself to Hanold’s conclusion that there will be a $0.10-0.15/Mcfe reduction for EQT. The analyst adds, “EQT shares are currently trading at just 4.4x our 2020 EBITDA, a slight discount to peers, despite having an FCF yield that could reach 10+%. We acknowledge the risk of a few bumps in the road with the new strategies, but the new team appears positioned to execute at EQT’s scale.”To this end, the analyst boosted the rating to Outperform and increased the price target from $16 to $17. This conveys his confidence in EQT’s ability to soar 88% over the next twelve months. (To watch Hanold’s track record, click here)Most analysts back Hanold's confident take on the gas giant, as TipRanks analytics showcase EQT as a Strong Buy. Based on 4 analysts polled by TipRanks in the last 3 months, 3 rate a Buy on the stock stock while one says "hold." The 12-month average price target stands at $14.00, marking a nearly 60% upside from where the stock is currently trading. (See EQT stock analysis on TipRanks)
SAN DIEGO, CA / ACCESSWIRE / November 19, 2019 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in EQT Corporation (NYSE: EQT) shares. Investors, who purchased ...
The CEO of the nation's largest independent natural gas driller says it comes down to three things: "It's what you do, it's how you do it, it's who's doing it."
STOCKHOLM , Nov. 6, 2019 /PRNewswire/ -- EQT brings in GIC, a large institutional investor, in a 9.9% minority stake sale in Anticimex With the partnership, Anticimex aims to internationalize ...
The Pittsburgh-based companies, which are now separately owned and managed, work to get to know one another.
EQT Corp, the biggest U.S. natural gas producer, said on Thursday it cut its capital expenditure guidance for 2019 and 2020 as new management highlighted their plans to deal with low energy prices. EQT cut its expected 2019 capex by $115 million and reduced its planned 2020 spending forecast by $525 million from its prior 2019 guidance. Despite the cut in 2019 capex, the company said in its third quarter earnings release that it was maintaining its 2019 full-year production guidance of 1,490-1,510 billion cubic feet equivalent (bcfe).
EQT Corp. executives gave investors a wider look at its plans for the next year and beyond, with a commitment to generate $1.5 billion to take a bite out of the driller's debt with the sale of its equity stake in Equitrans Midstream Corp. and noncore assets out of its vast inventory. EQT (NYSE: EQT) said in its third-quarter conference call it would reduce its overall corporate debt by 30 percent by the middle of 2020 through the strategy that will help it maintain investment-grade rating. The biggest stake would come from the sale of its remaining stock in Equitrans Midstream (NYSE: ETRN), the Pittsburgh-based pipeline company that had been spun out of EQT in 2018.
It's the first time the company has reported earnings that were fully under the tenure of the new management team.
STOCKHOLM , Oct. 25, 2019 /PRNewswire/ -- EQT AB's Q3 2019 announcement will be published on Tuesday 5 November 2019 at approximately 07:30 CET . In addition, a telephone conference will be held at 08:30 ...
Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million liquid to invest in a hedge fund) by spending enormous resources on analyzing and uncovering data about small-cap stocks that the […]
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of EQT Corporation and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
There are big opportunities ahead for the natural gas industry and the country, including opening up liquified natural gas for export so that customers around the world will be able to benefit from the U.S. shale revolution, EQT CEO Toby Z. Rice told an industry conference Wednesday. The natural gas industry has been hit in recent months by low commodity prices, which has cut back on drilling in Appalachia and elsewhere as well as sending waves of layoffs throughout much of the industry. "Natural gas is able to compete on a global stage," Rice said during an appearance Wednesday at Shale Insight 2019, the annual conference of the Marcellus Shale Coalition, Ohio Oil and Gas Association and the West Virginia Oil and Natural Gas Association that is being held at the David L. Lawrence Convention Center.
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, continues its investigation of certain directors and officers of EQT Corporation (“EQT” or the “Company”) (EQT) for breaching their fiduciary duties to the Company and its shareholders. If you are an EQT shareholder, you may contact attorney Joe Pettigrew for additional information at 844-818-6982 or email@example.com. Scott+Scott is investigating whether certain members of EQT’s board of directors misled investors in connection with EQT’s acquisition of Rice Energy Inc. (“Rice”), a rival gas producer.
Today, Oct. 18, marks 100 days since the new leadership team took over at EQT Corp., but investors and industry observers will apparently have to wait another few days before the country’s largest independent natural gas driller goes into detail about its new direction. Rice will appear at a “fireside chat” Oct. 23 at the Shale Insight conference in downtown Pittsburgh. Then on Oct. 31, EQT (NYSE: EQT) will release third-quarter earnings and hold a conference call with analysts.